U.S. drugmaker Pfizer PFE.N is going "all in" to develop its experimental obesity drug and has been recruiting more experts in that area, Chief Executive ...

The Wabash Valley Community Foundation has landed a $6.5 million grant toward an $11.3 million modernization and renovation ...

The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.

The CEO of Germany's Merck KGaA said a recovery in sales growth at its existing business means it can take a cautious ...

The global vaccine storage equipment market, valued at US$0.82 billion in 2023, is forecasted to grow at a robust CAGR of 7.2%, reaching US$0.86 billion in 2024 and an impressive US$1.21 billion by ...

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...

We recently compiled a list of the Jim Cramer Recently Discussed These 17 Stocks And Chinese Hackers. In this article, we are ...

Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year.

This item was corrected at 6:00 p.m. ET to show that Michael Osso is chief executive officer of the Crohn's & Colitis Foundation, not of Eli Lilly. Top investment firms expect non-US stocks to ...

Omvoh is the first biologic treatment in more than 15 years to have disclosed two-year Phase 3 efficacy data in Crohn's disease at the time of approval. 2 "The burden of Crohn's disease on patients' ...

We recently compiled a list of the Jim Cramer Discusses Joe Rogan, Elon Musk, And These 13 Stocks. In this article, we are ...

David Ricks, CEO of Eli Lilly, noted on the 14th (local time) during a presentation at the 43rd JPMorgan Healthcare Conference (JPM 2025) held at The Westin St. Francis in San Francisco ...